Drug research

Losmapimod oral tablet

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Losmapimod Safety and Efficacy in COVID-19NCT04511819	Fulcrum Therapeutics	Phase 3	Terminated	2021-03-31Actual
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)NCT04003974	Fulcrum Therapeutics	Phase 2	Completed	2021-01-28Actual

Fulcrum TherapeuticsTerminatedPrimary completion: 2021-03-31 · Actual

Trial details

Fulcrum TherapeuticsCompletedPrimary completion: 2021-01-28 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.